18942640Knight D, Peterson AC, Rini BI, Harlin H, Gajewski TF, Stadler WMThe ProstateAdenocarcinoma; Antigens, Surface; Glutamate Carboxypeptidase II; Peptide Fragments; Prostatic NeoplasmsCancer Vaccines; Epitopes; HLA-A2 Antigen; Humans; Interferon-gamma; Interleukin-12; Male; Neoplasm Metastasis; Patient Selection; Recombinant Proteins; T-LymphocytesThe HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer. Prostate. 2009 Feb 01; 69(2):142-8.Prostate2009-02-01T00:00:002009The HLA-A2-restricted PSMA peptide LLHETDSAV is poorly immunogenic in patients with metastatic prostate cancer.prns:fullNamefull nameprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:hasSubjectAreaMajorTopicListhas major subject area listprns:hasSubjectAreaMinorTopicListhas minor subject area listprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed Identifiervivo:authorRankauthor rank in publicationAuthorshipDepartmentvivo:hasSubjectAreahas subject areavivo:hrJobTitleHR job titleInformation Resourcevivo:informationResourceInAuthorshipauthorsvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcePositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonD000230Disorders29111600.582251AdenocarcinomaD000954Chemicals & Drugs551010.971229Antigens, SurfaceD000939Chemicals & DrugsPhenomena1172550.93119EpitopesD010446Chemicals & Drugs2134600.839276Peptide FragmentsD011471Disorders23517080.438658Prostatic NeoplasmsAuthorship 363985Authorship 363996D007371Chemicals & Drugs1554440.841977Interferon-gammaD015789Chemicals & Drugs15310.985361HLA-A2 AntigenD006801Living Beings2262862810.130052HumansD008297Physiology1931408600.201617Male0.3498660.08746642authors10.2516has subject areaD009362Disorders26910560.715963Neoplasm MetastasisD018664Chemicals & Drugs471080.932342Interleukin-12D019496Chemicals & Drugs461560.877607Cancer VaccinesD011994Chemicals & Drugs36610140.836793Recombinant ProteinsD043425Chemicals & Drugs680.995966Glutamate Carboxypeptidase IID018579Concepts & IdeasProcedures3056850.733031Patient SelectionD013601Anatomy30511950.618068T-LymphocytesMedicinePathologyUniversity of ChicagoWalter M.StadlerWalter M. Stadler41.78927490000000-87.601250000000001904Stadler, Walter M.ProfessorThomas F.GajewskiThomas F. Gajewski41.78927490000000-87.60125000000000355Gajewski, Thomas F.Professortrue1ProfessorProfessortrue1ProfessorProfessor